Ameritas Investment Partners, Inc. - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 95 filers reported holding ALBIREO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$62,152
+130.2%
1,4190.0%0.00%
+100.0%
Q3 2022$27,000
-3.6%
1,4190.0%0.00%0.0%
Q2 2022$28,000
-33.3%
1,4190.0%0.00%
-50.0%
Q1 2022$42,000
+27.3%
1,4190.0%0.00%
+100.0%
Q4 2021$33,000
-25.0%
1,4190.0%0.00%
-50.0%
Q3 2021$44,000
-12.0%
1,4190.0%0.00%0.0%
Q2 2021$50,0000.0%1,4190.0%0.00%0.0%
Q1 2021$50,000
-5.7%
1,4190.0%0.00%0.0%
Q4 2020$53,000
+60.6%
1,419
+45.7%
0.00%
+100.0%
Q3 2020$33,000
+26.9%
9740.0%0.00%0.0%
Q2 2020$26,000
+62.5%
9740.0%0.00%0.0%
Q1 2020$16,000
-5.9%
974
+41.6%
0.00%0.0%
Q4 2019$17,000
+21.4%
6880.0%0.00%0.0%
Q3 2019$14,000
-36.4%
6880.0%0.00%0.0%
Q2 2019$22,0000.0%6880.0%0.00%0.0%
Q1 2019$22,000
+29.4%
6880.0%0.00%0.0%
Q4 2018$17,000
-26.1%
6880.0%0.00%0.0%
Q3 2018$23,000
-4.2%
6880.0%0.00%0.0%
Q2 2018$24,0006880.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Prosight Management, LP 174,791$6,556,0003.03%
Sio Capital Management, LLC 354,210$13,286,0002.72%
Birchview Capital, LP 92,000$3,451,0001.99%
Chicago Capital, LLC 618,263$23,191,0001.04%
Perceptive Advisors 2,360,139$88,529,0000.95%
Endurant Capital Management LP 42,292$1,586,0000.57%
Artal Group S.A. 700,000$26,257,0000.56%
Cormorant Asset Management, LP 500,000$18,755,0000.45%
Samsara BioCapital, LLC 100,000$3,751,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 257,372$9,654,0000.34%
View complete list of ALBIREO PHARMA INC shareholders